Navigation Links
Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharma's Fall Line Up!
Date:12/20/2007

NEW YORK, Aug. 10 /PRNewswire/ -- ExL Pharma is pleased to announce the fall conference line up which covers many of the leading issues that are impacting the pharmaceutical industry today. The events that are currently scheduled offer educational and networking opportunities for Clinical, Marketing, R&D, and Medical Affairs executives from large to small pharmaceutical, biotech and medical technology companies.

Listed below are details on some of the featured events and highlights from those conferences:

September 10-11th, Philadelphia, PA

3rd Clinical Performance Metrics & Benchmarking- Measuring and Improving

Clinical Performance to Maximize Efficiency

The 2007 Metrics event features 5 Case Study examples from Pfizer, Merck,

Allergan, Astrazeneca, and Sanofi-Aventis on different clinical

performance measurement applications.

September 13-14th, San Francisco, CA

6th Investigator-Initiated Trials- Ensuring Quality Studies through

Increased Collaboration,

Participate in the first ever IIT working group and help shape best

practices and form future guidelines.

September 24-25th, Annapolis, MD

3rd Merging EHR & eClinical Technologies- Implementing the Technology for

Convergence

This event features presentations from Pfizer, Allscripts, Johnson &

Johnson, HL7 and CDISC discussing strategies for integrating drug

development and healthcare IT.

October 22-24, Princeton, NJ

Digital Pharma- Accelerating to the Next Generation of Marketing with Web

2.0

Hear leading pharmaceutical companies such as Abbott, Wyeth and Bayer

discuss how they are taking full advantage of Web 2.0 marketing strategies

to communicate with consumers and physicians.

November 5-6th, Princeton, NJ

3rd Pharmaceutical Meeting Planners Summit- The Ideal Networking

Environment for Pharmaceutical Meeting Planners

This newly updated agenda features perspectives from 13 different

pharmaceutical speakers which will offer an ideal learning experience for

participants.

November 8-9th, Orlando, FL

3rd MSL Next Practices- Communicating MSL Value to Business Partners

The winner of the "Best Industry Wide MSL Meeting Award for 2006" is back

focusing on next practices to be taken by MSL teams in order to enhance

value. Speakers include participants from Amgen, Genentech, Novo-Nordisk

and more.

To view our full list of upcoming conferences and webinars and details on our expert speaking faculties or to REGISTER, Log onto: http://www.exlpharma.com.

*Please mention Registration Code: EPR89 when registering

About ExL

ExL Pharma, a division of ExL Events, Inc., is an emerging leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.


'/>"/>
SOURCE ExL Pharma
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
2. ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
3. Merck Will Obtain Blockbuster Antidiabetic Drug Sales in Type 2 Diabetes Market by 2011
4. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
5. NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
6. Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC
7. PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis
8. AMDL Expands Drug Distribution in China With Additional Agreement, Valued at $2.3 Million Annually
9. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
10. iCAD, Inc. Awarded Two Additional Patents for Its Computer-Aided Detection Technology
11. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... a published evaluation of multiple immunoassay-based threat detection technologies by researchers from ... PathSensors’ CANARY® biosensor threat detection technology was found to have the best ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The Greater ... a new partnership with Compass Research . GGI's mission is to advance global ... to a child in need in honor of each clinical trial volunteer. The vision ...
(Date:2/23/2017)... DIEGO and SAN FRANCISCO ... a privately-held regenerative medicine company, and Beyond Type 1, ... with type 1 diabetes, today announced a grant from ... a functional cure for type 1 and other insulin-requiring ... ViaCyte has been developing innovative stem cell-derived cell replacement ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel , ... Research Systems, LLC (KRS) clinical development program. KRS is a neurotechnology spin-out ... research and clinical applications. The terms of the transaction were not disclosed. ...
Breaking Biology Technology:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Biology News(10 mins):